French Biotech Stocks

Sanofi

Market Cap: €96.1b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Sartorius Stedim Biotech

Market Cap: €17.8b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Ipsen

Market Cap: €12.9b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

Eurofins Scientific

Market Cap: €11.9b

Provides various analytical testing and laboratory services worldwide.

Virbac

Market Cap: €3.1b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

DBV Technologies

Market Cap: €1.1b

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

Vetoquinol

Market Cap: €1.0b

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Valneva

Market Cap: €825.3m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Boiron

Market Cap: €484.4m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Cellectis

Market Cap: €248.8m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Eurobio Scientific Société anonyme

Market Cap: €236.1m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology.

Euroapi

Market Cap: €207.0m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Innate Pharma

Market Cap: €131.8m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

AB Science

Market Cap: €97.6m

A clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.

OSE Immunotherapeutics

Market Cap: €96.4m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Eurofins-Cerep

Market Cap: €87.8m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

Novacyt

Market Cap: €27.5m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

Valbiotis

Market Cap: €24.4m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

genOway Société anonyme

Market Cap: €22.8m

A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.

Aelis Farma

Market Cap: €18.8m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

GenSight Biologics

Market Cap: €17.9m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

Poxel

Market Cap: €14.8m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Oncodesign Precision Medicine Société anonyme

Market Cap: €9.0m

A biopharmaceutical company, engages in the precision medicine business.

IntegraGen

Market Cap: €1.0m

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

Neovacs

Market Cap: €762.0

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.